Author

L. B. Egoryan

Observed names: Lidia B. Egoryan, Л. Б. Егорян, Л.Б. Егорян

Institution: Botkin Hospital

Observed institutions: Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation, Botkin Hospital

ORCID: 0000-0001-8077-5225

Observed ORCID: 0000-0001-8077-5225

OpenAlex ID: A5092396256

Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study

2023 · O. Yu. Vinogradova, D. I. Shikhbabaeva, et al. · Oncohematology · 4

Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study

2024 · O. Yu. Vinogradova, M. M. Pankraskina, et al. · Oncohematology · 1

Contemporary Interpretations of Ophthalmological Manifestations of Chronic Myeloproliferative Neoplasms

2023 · Larisa K. Moshetova, Lidia B. Egoryan, et al. · Annals of the Russian academy of medical sciences · 1

Primary and secondary myelofibrosis: ophthalmological manifestations at onset and during therapy

2025 · O. Yu. Vinogradova, L. B. Egoryan, et al. · Oncohematology

Central Retinal Vein Occlusion as the Debut of a Chronic Myeloproliferative Neoplasm

2024 · L. K. Moshetova, L. B. Egoryan, et al. · Ural Medical Journal

Первичный, постполицитемический, посттромбоцитемический миелофиброз: офтальмологические проявления в дебюте и в процессе терапии

· О. Ю. Виноградова, Л. Б. Егорян, et al. · CyberLeninK (CyberLeninka)

Works count: 7

Citation count: 6

H-index: 1

I10-index: